Skip to main content
. 2020 Dec 4;27(3):206–215. doi: 10.1159/000512156

Table 2.

Prevalence of past-year substance use diagnoses and other psychiatric diagnoses in emerging adults and adults

Diagnoses (N = 499), n Emerging adults (n = 149), % Adults (n = 350), % χ2 p value Effect size
Alcohol (F10) 239 32.1 57.5 25.19 0.000 0.23
Opioids (F11) 108 21.2 23.3 0.25 0.614 0.02
Cannabis (F12) 213 74.5 32.7 68.65 0.000 0.38
Sedatives (F13) 164 42.3 31.3 5.29 0.021 0.11
Cocaine (F14) 20 7.3 2.9 4.59 0.032 0.10
Stimulants (F15) 188 54.0 33.6 16.97 0.000 0.19
Hallucinogens (F16) 11 6.6 0.6 15.45 0.000 0.18
Multiple drugs (F19) 33 10.2 5.6 3.22 0.073 0.08
Affective disorders (F30–39) 92 21.5 17.1 1.31 0.253 0.05
Anxiety disorders (F40–48) 133 30.9 24.9 1.93 0.164 0.06
Personality disorders (F60–69) 66 12.1 13.7 0.24 0.622 0.02
ADHD (F90) 75 24.2 11.1 13.87 0.000 0.17
Other psychiatric disorders 49 13.4 8.3 3.11 0.078 0.08
Any mental disordera 265 63.8 48.6 9.68 0.002 0.14

ADHD, attention deficit hyperactivity disorder. Significant p values (<0.05) are in bold.

a

The most prevalent past-year comorbid mental disorders were affective disorders and anxiety disorders.